Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)

10. april 2008 opdateret af: Weill Medical College of Cornell University

Peri-Operative Morbidity and Quality of Life After CABG

It is the long term objective of this study to preserve or improve the quality of life and to prevent deterioration in physical and mental function following myocardial revascularization among bypass surgery patients.

Studieoversigt

Detaljeret beskrivelse

The objective of this study is to compare the efficacy of two strategies of intra-operative hemodynamic management in preventing peri-operative cardiac, cognitive and neurologic morbidity and mortality and postoperative deterioration in the patient's quality of life.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

248

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • New York
      • New York, New York, Forenede Stater, 10065
        • New York Presbyterian Hospital-Weill Cornell Medical College

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  1. Patients had to be undergoing elective CABG, without concomitant valve or other cardiac surgery.
  2. Patients also had to be able to perform the neuropsychologic tests, and to provide informed consent.

Exclusion Criteria:

  1. Patients who refused to participate in the study.
  2. Patients who live too far away from NYC to be able to come back for follow up at six months post-operatively.
  3. Patients who had either valvular replacement and aortic amd mitral an aneurysm repair, or other cardiothoracic surgery.
  4. Patients who were unable to complete the neuropsychologic test.
  5. Patient who were part of another CABG study.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Crossover opgave
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: 1
In this group (Low) the goal was to maintain MAP between 50-60 mm Hg during CPB.
Patients were randomized to one of two groups. In the first group (Low) the goal was to maintain MAP between 50-60 mm Hg during CPB. In the second group (High), the goal was to maintain MAP between 80-100 mm Hg. In both groups, CPB flow was held constant at 1.6 L/min/M2 (cool) and 2.4 L/min/M2 (warm) and vasoactive drugs (nitroglycerin or phenylephrine) were used to maintain MAP in the desired range. MAP was controlled in this fashion from the onset of CPB through separation from CPB began.
Andre navne:
  • Mean Arterial Pressure during cardiopulmonary bypass 50-60 mm/Hg (control) vs. 80-100 mm/Hg (experimental)
Eksperimentel: 2
In this group (High), the goal was to maintain MAP between 80-100 mm Hg during CPB.
Patients were randomized to one of two groups. In the first group (Low) the goal was to maintain MAP between 50-60 mm Hg during CPB. In the second group (High), the goal was to maintain MAP between 80-100 mm Hg. In both groups, CPB flow was held constant at 1.6 L/min/M2 (cool) and 2.4 L/min/M2 (warm) and vasoactive drugs (nitroglycerin or phenylephrine) were used to maintain MAP in the desired range. MAP was controlled in this fashion from the onset of CPB through separation from CPB began.
Andre navne:
  • Mean Arterial Pressure during cardiopulmonary bypass 50-60 mm/Hg (control) vs. 80-100 mm/Hg (experimental)

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Cardiac morbidity
Tidsramme: 6-months after surgery
6-months after surgery
Neurologic morbidity
Tidsramme: 6-months after surgery
6-months after surgery
Mortality
Tidsramme: 6-months after surgery
6-months after surgery
Functional status
Tidsramme: 6-months after surgery
6-months after surgery
Neurocognitive function
Tidsramme: 6-months after surgery
6-months after surgery

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 1991

Studieafslutning (Faktiske)

1. september 1994

Datoer for studieregistrering

Først indsendt

3. november 2005

Først indsendt, der opfyldte QC-kriterier

3. november 2005

Først opslået (Skøn)

4. november 2005

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

11. april 2008

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

10. april 2008

Sidst verificeret

1. april 2008

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 0001004169 (Formerly 0100-006)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner